Medicenna Therapeutics Corp. - COM (MDNAF)

CUSIP: 58490H107

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COM
Total 13F shares
9,595,263
Share change
+545,597
Total reported value
$4,431,339
Price per share
$0.46
Number of holders
27
Value change
+$73,549
Number of buys
12
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 58490H107?
CUSIP 58490H107 identifies MDNAF - Medicenna Therapeutics Corp. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Medicenna Therapeutics Corp. - COM (MDNAF) as of Q4 2022

As of 31 Dec 2022, Medicenna Therapeutics Corp. - COM (MDNAF) was held by 27 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 9,595,263 shares. The largest 10 holders included AIGH Capital Management LLC, Worth Venture Partners, LLC, Hudson Bay Capital Management LP, DAFNA Capital Management LLC, Alyeska Investment Group, L.P., Verition Fund Management LLC, Sigma Planning Corp, RENAISSANCE TECHNOLOGIES LLC, LETKO, BROSSEAU & ASSOCIATES INC, and Royal Bank of Canada. This page lists 27 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.